UVGI efficacy measures the effectiveness of ultraviolet germicidal irradiation systems in inactivating airborne pathogens and surface microorganisms. This metric quantifies the percentage of microorganisms destroyed when exposed to specific UV-C dosages, typically expressed as colony-forming units (CFU) reduced per cubic meter of air treated.
Technical Specifications
Efficacy depends on UV-C dosage, measured in microwatts per square centimeter per second (µW/cm²/s), and exposure time. Standard efficacy testing follows ASHRAE 52.2 protocols using MS2 bacteriophage or Mycobacterium terrae as surrogate organisms. Most commercial UVGI systems achieve 90-99 percent efficacy against common airborne pathogens including influenza, measles, and tuberculosis when properly maintained with adequate lamp output and air velocity control.
Practical Considerations
Efficacy degrades over time as UV lamps age; replacement typically occurs at 70-80 percent of initial output after 8,000-10,000 operating hours. Dust accumulation on lamp surfaces reduces efficacy by 10-30 percent annually, necessitating quarterly cleaning schedules. System design, including air distribution patterns and residence time within the UV field, significantly impacts real-world efficacy performance.